No Evidence COVID-19 Vaccines Will Block Spread of Coronavirus
On Nov. 9, 2020, Pfizer, Inc. announced that the experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19 it developed in partnership with Germany’s BioNTech SE had an efficacy rate of 90 percent, based on the results of human clinical trials on the vaccine.1 2 3 This news was followed up a week later with an […]
Peruvian Man Suffers Guillain-Barré-like Symptoms After Receiving Sinopharm COVID-19 Vaccine
On Dec. 11, 2020, Peru’s National Institute of Health (INS) said it was temporarily suspending the Phase 1 clinical trial of an experimental COVID-19 vaccine developed by Sinopharm Group Co. Ltd. of Shanghai, China after one of the participants in the trial who got the vaccine showed difficulty in moving his arms and legs—symptoms of […]
China Administers Unlicensed Experimental COVID-19 Vaccines to Its Citizens
China is the first country in the world to vaccinate its citizens with experimental COVID-19 vaccines that are still undergoing clinical trials. No other country has vaccinated people on such a large scale with experimental COVID-19 vaccines prior to final regulatory approval for general use as China has done with their coronavirus vaccine candidates.1 Chinese […]
